ALK-Abello A/S
F:4AJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ALK-Abello A/S
F:4AJ
|
DK |
|
M
|
Mitsui Fudosan Co Ltd
XMUN:MFU
|
JP |
|
S
|
Sherwin-Williams Co
DUS:SJ3
|
US |
|
Kimberly-Clark de Mexico SAB de CV
OTC:KCDMF
|
MX |
|
T
|
Tractor Supply Co
F:TR4
|
US |
|
N
|
NetApp Inc
SWB:NTA
|
US |
|
Controladora Vuela Compania de Aviacion SAB de CV
F:2CDA
|
MX |
|
A
|
Anima Holding SpA
SWB:124
|
IT |
|
Viel et Compagnie SA
PAR:VIL
|
FR |
|
Publicis Groupe SA
PAR:PUB
|
FR |
|
ASM International NV
AEX:ASM
|
NL |
|
S
|
Srinanaporn Marketing PCL
SET:SNNP
|
TH |
|
Quantumscape Corp
NASDAQ:QS
|
US |
|
F
|
Fujitec Co Ltd
F:FJC
|
JP |
|
Bridgestone Corp
F:BGT
|
JP |
|
Cheesecake Factory Inc
NASDAQ:CAKE
|
US |
|
A
|
Abasca Resources Inc
XTSX:ABA
|
CA |
|
AngloGold Ashanti Ltd
F:AOD
|
ZA |
|
U
|
United Rentals Inc
F:UR3
|
US |
Bankruptcy Probability
ALK-Abello A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ALK-Abello A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
ALK-Abello A/S
CSE:ALK B
|
57.1B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
919.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
535.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
206.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ALK-Abello A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ALK-Abello A/S has total debt of 355m DKK. This includes both short-term (0 DKK) and long-term (355m DKK) debt.
You can find a full breakdown on its Balance Sheet.
